Daniel Anderson

Professor

Department
Department of Chemical Engineering
Technology Areas
Biotechnology: DNA & RNA Editing, Biomedical Devices & Systems, Sensors & Monitoring, Synthetic Biology / Chemicals & Materials: Catalysis & Synthesis, Nanotechnology & Nanomaterials, Polymers, Composites / Drug Discovery and Research Tools: Genomics & Proteomics, Cell Interrogation, Cell Lines & Organoids, Cell Culture / Therapeutics: Nucleic Acids, Small Molecules, Cell Based Therapy, Vaccines, Proteins & Antibodies, Regenerative Medicine / Drug Delivery: Microparticles & Nanoparticles, Vectors & Virus like Particles / Artificial Intelligence (AI) and Machine Learning (ML) / Sensing & Imaging: Imaging, Chemical & Radiation Sensing / Energy & Distribution: Electrochemical Devices / Biomaterials & Bioelectronics: Medical Device Coatings, Health Monitoring / Computer Science: Bioinformatics / Diagnostics: Assays

Pioneering smart materials for advancements in medical devices, drug delivery, and gene therapy, with a prolific publication record and significant impact across multiple disciplines.

Background and Experience

Daniel G. Anderson is a leading researcher in the fields of nanotherapeutics and biomaterials and has pioneered the development of smart materials. In addition to the Koch Institute, he holds appointments in MIT’s Department of Chemical Engineering, Institute for Medical Engineering and Science, and Harvard-MIT Division of Health Science and Technology. Anderson received a BA in mathematics and biology from the University of California at Santa Cruz and a PhD in molecular genetics from the University of California at Davis. Anderson’s work has led to advances in a range of areas, including medical devices, cell therapy, drug delivery, gene therapy and material science, and has resulted in the publication of more than 500 papers, patents, and patent applications. He is the recipient of the 2023 Wilhelm Exner Medal.

Awards and Honors

  • Work has resulted in the publication of more than 500 papers, patents, and patent applications
  • Wilhelm Exner Medal | 2023

Technologies

Amino Acid, Peptide, Polypeptide-Lipids (APPL) Derivatives and Uses Thereof

Technology / Case number: #14910Q
Kevin Love / Arturo Vegas / Delai Chen / Yi Chen / Yizhou Dong / Yunlong Zhang / Akinleye Alabi / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Lipid Compositions and Methods

Technology / Case number: #25115J
Sho Toyonaga / Theresa Raimondo / Dennis Shi / Daniel Anderson
Technology Areas: Drug Delivery
Impact Areas: Healthy Living
License

Biodegradable Lipid-Like Materials for Applications in siRNA Delivery

Technology / Case number: #15420
Kathryn Whitehead / Arturo Vegas / Yunlong Zhang / Joseph Dorkin / Robert Langer / Daniel Anderson
Technology Areas: Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

1,3,5-triazinane-2,4,6-trione (TNT) Derivatives and Uses Thereof

Technology / Case number: #15446
Delai Chen / Yizhou Dong / Ahmed Eltoukhy / Joseph Dorkin / Akinleye Alabi / Hao Yin / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Compositions and Methods to Deliver RNA to Extracellular Matrix Producing Cells

Technology / Case number: #25390J
Sho Toyonaga / Theresa Raimondo / Dennis Shi / Daniel Anderson
Technology Areas: Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

A Novel Injectable Thiol-Acrylate Poly(ethylene Glycol) Hydrogel for Sustained Release of Methylprednisolone Sodium Succinate

Technology / Case number: #14439J
Eric Woodard / Christopher Pritchard / Daniel Siegwart / Timothy O'Shea / Francis Reynolds / Jonathan Slotkin / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Self- Regulated Peptide Hydrogel for Closed Loop Insulin Delivery

Technology / Case number: #15056J
Zhen Gu / Alex Aimetti / Robert Langer / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery
Impact Areas: Healthy Living
License

Novel Glucose-Responsive Insulin Formulations Using Chemically Modified Insulin Derivatives and Non-Covalent Insulin-Binding Molecules

Technology / Case number: #15976J
Arturo Vegas / Yair Levi / Yunlong Zhang / Benjamin Tang / Hung-Chieh (Danny) Chou / Kun Xue / Matthew Webber / Rosemary Kanasty / Robert Langer / Daniel Anderson
Technology Areas: Chemicals & Materials / Computer Science / Therapeutics
Impact Areas: Healthy Living
License

Poly(B-Amino Alcohols), Their Preparation and Uses Thereof

Technology / Case number: #14035QJ
Minglin Ma / Wendy Liu / Robert Langer / Daniel Anderson
Technology Areas: Biomaterials & Bioelectronics / Chemicals & Materials
Impact Areas: Healthy Living
License

Biodegradable Polyamine-Fatty Acid Derived Lipidoids for Drug Delivery

Technology / Case number: #16367
Joseph Dorkin / Owen Fenton / Rebecca McClellan / Daniel Anderson
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.